During hemodialytic treatment, the blood is exposed to a different condition from blood vessels, because the blood is circulating in a hemodialysis circuit. In the hemodialysis circuit, the blood coagulates faster. Therefore, treatment of anticoagulants is necessary in order to inhibit blood coagulation in the hemodialysis circuit. Treatment of a large amount of anticoagulants, however, causes hemorrhagic diathesis. Thus, development of materials for circuit that prevent blood coagulation is expected. To examine blood coagulation in the hemodialysis circuit, we carried out the experiments to assess the activation and effects of blood coagulation factors caused by the contacts of blood with test tubes made of glass (glass and siliconized glass) and polymer (polytetrafluoroethylen/perfluoroalkoxyethylen, polymethylpentene, polypropylene and polystyrene). As a result, whole blood coagulation time of a polymer group was significantly delayed (p<0.05) compared to that of a glass group. Furthermore, a thrombin-like activity in the glass group was significantly higher (p<0.05) than that of the polymer group. The formation of the thrombin-like substances on the wall of test tubes likely affected the shortening of the blood coagulation time. Thrombin-like substances might adhere on the wall of the test tube by binding with heparin-binding site while the enzymatic site for a coagulant is probably still active. Therefore, heparin probably could not inhibit the thrombin-like activity bound on the glass wall. Results of our experiments suggest that the polymer materials, especially polypropylene and polystyrene, are blood compatible compared with other materials.
View full abstract